These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18234531)

  • 41. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
    Mariotti C; Solari A; Torta D; Marano L; Fiorentini C; Di Donato S
    Neurology; 2003 May; 60(10):1676-9. PubMed ID: 12771264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
    Cooper JM; Schapira AH
    Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antioxidant use in Friedreich ataxia.
    Myers L; Farmer JM; Wilson RB; Friedman L; Tsou A; Perlman SL; Subramony SH; Gomez CM; Ashizawa T; Wilmot GR; Mathews KD; Balcer LJ; Lynch DR
    J Neurol Sci; 2008 Apr; 267(1-2):174-6. PubMed ID: 17988688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exonic deletions of FXN and early-onset Friedreich ataxia.
    Anheim M; Mariani LL; Calvas P; Cheuret E; Zagnoli F; Odent S; Seguela C; Marelli C; Fritsch M; Delaunoy JP; Brice A; Dürr A; Koenig M
    Arch Neurol; 2012 Jul; 69(7):912-6. PubMed ID: 22409940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review.
    Jain P; Badgujar L; Spoorendonk J; Buesch K
    Ther Adv Rare Dis; 2022; 3():26330040221139872. PubMed ID: 37180421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up.
    Pineda M; Montero R; Aracil A; O'Callaghan MM; Mas A; Espinos C; Martinez-Rubio D; Palau F; Navas P; Briones P; Artuch R
    Mov Disord; 2010 Jul; 25(9):1262-8. PubMed ID: 20629161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.
    Pousset F; Legrand L; Monin ML; Ewenczyk C; Charles P; Komajda M; Brice A; Pandolfo M; Isnard R; Tezenas du Montcel S; Durr A
    JAMA Neurol; 2015 Nov; 72(11):1334-41. PubMed ID: 26414159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring.
    Buyse G; Mertens L; Di Salvo G; Matthijs I; Weidemann F; Eyskens B; Goossens W; Goemans N; Sutherland GR; Van Hove JL
    Neurology; 2003 May; 60(10):1679-81. PubMed ID: 12771265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
    Seznec H; Simon D; Monassier L; Criqui-Filipe P; Gansmuller A; Rustin P; Koenig M; Puccio H
    Hum Mol Genet; 2004 May; 13(10):1017-24. PubMed ID: 15028670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia.
    Jauslin ML; Vertuani S; Durini E; Buzzoni L; Ciliberti N; Verdecchia S; Palozza P; Meier T; Manfredini S
    Mol Cell Biochem; 2007 Aug; 302(1-2):79-85. PubMed ID: 17476463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.
    Costantini A; Laureti T; Pala MI; Colangeli M; Cavalieri S; Pozzi E; Brusco A; Salvarani S; Serrati C; Fancellu R
    J Neurol; 2016 Nov; 263(11):2170-2178. PubMed ID: 27488863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of antioxidants in Friedreich's ataxia treatment.
    Rustin P
    Expert Opin Investig Drugs; 2003 Apr; 12(4):569-75. PubMed ID: 12665413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
    Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of up to 12 years of follow-up of Friedreich ataxia utilising four measurement tools.
    Tai G; Corben LA; Gurrin L; Yiu EM; Churchyard A; Fahey M; Hoare B; Downie S; Delatycki MB
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):660-6. PubMed ID: 25112308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone Deficiency.
    Shinnick JE; Schadt K; Strawser C; Wilcox N; Perlman SL; Wilmot GR; Gomez CM; Mathews KD; Yoon G; Zesiewicz T; Hoyle C; Subramony SH; Yiu EM; Delatycki MB; Brocht AF; Farmer JM; Lynch DR
    J Child Neurol; 2016 Aug; 31(9):1161-5. PubMed ID: 27071470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Congestive heart failure and cardiac thrombus as first presentations of Friedreich ataxia.
    Tsao CY; Lo WD; Craenen J
    Pediatr Neurol; 1992; 8(4):313-4. PubMed ID: 1388425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Idebenone - monograph.
    Altern Med Rev; 2001 Feb; 6(1):83-6. PubMed ID: 11207459
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined Cerebellar Proton MR Spectroscopy and DWI Study of Patients with Friedreich's Ataxia.
    Gramegna LL; Tonon C; Manners DN; Pini A; Rinaldi R; Zanigni S; Bianchini C; Evangelisti S; Fortuna F; Carelli V; Testa C; Lodi R
    Cerebellum; 2017 Feb; 16(1):82-88. PubMed ID: 26897753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?
    Cano SJ; Hobart JC; Hart PE; Korlipara LV; Schapira AH; Cooper JM
    Mov Disord; 2005 Dec; 20(12):1585-91. PubMed ID: 16114019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterizing gait, locomotor status, and disease severity in children and adolescents with Friedreich ataxia.
    Croarkin E; Maring J; Pfalzer L; Harris-Love M; Siegel K; DiProspero N
    J Neurol Phys Ther; 2009 Sep; 33(3):144-9. PubMed ID: 19809393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.